ADIM
KEY icon

Alpha DNA Investment Management’s KeyCorp KEY Stock Holding History

Alpha DNA Investment Management’s Portfolio KEY Stock Details KEY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-63,390
Closed -$1.42M – 144
2022
Q1 		$1.42M Buy
+63,390
New +$1.58M 1% 22
2021
Q2 		– Sell
-2,173
Closed -$43K – 372
2021
Q1 		$43K Sell
2,173
-282
-11% -$5.44K 0.05% 193
2020
Q4 		$40K Buy
+2,455
New +$35.8K 0.04% 197

Other funds holding KEY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Alpha DNA Investment Management's KEY Position: Q2 2022 in Review

Alpha DNA Investment Management sold out of KeyCorp (KEY) in Q2 2022, closing a stake of 63,390 shares — an estimated $1.42M sold.

Alpha DNA Investment Management first reported a position in KEY in Q4 2020 and held it in 3 quarters. The position peaked at $1.42M in Q1 2022. 811 funds tracked by Wall St. Rank hold KEY as of Q2 2022.

  • Alpha DNA Investment Management reported no remaining KeyCorp position as of Q2 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 63,390 KeyCorp shares in Q2 2022, an estimated $1.42M.
  • Alpha DNA Investment Management first reported a position in KeyCorp in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's KeyCorp position peaked at $1.42M in Q1 2022.
  • 811 funds tracked by Wall St. Rank held KeyCorp as of Q2 2022.

Based on Alpha DNA Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.